Doximity, Inc.

NYSE:DOCS

Medical - Healthcare Information Services

Healthcare
$30.67 -0.44%

-$0.09 today

Market cap
$5.47B
Beta
1.29
P/E (TTM)
19.2
EPS (TTM)
$1.06
52W Low $17.15High $76.51

Volume 2.27M

Average 3.89M

DOCS Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Doximity, Inc.NYSE: DOCS

Capital Expenditures · Q2 FY2027 · quarter ended Sep 2026

Capital expenditures turns positive

Q2 FY2027 capital expenditures was $0, compared with -$2.37M a year earlier. Trailing-twelve-month capital expenditures was -$4.69M. Over 3 fiscal years it compounded at +13.2% a year.

Context

  • Capital expenditures amounted to 1.4% of revenue in FY2026, up 0.2 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.
  • FY2026 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly capital expenditures holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$1.17M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0+100.0% QoQ
Last fiscal yearMar 2026
-$8.96M+37.4% YoY
LTMSep 2026
-$4.69M-38.4% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+100.0%——
1 year+37.4%——
3-year CAGR+13.2%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2026
(8.96M) USD
Year-over-year change
-37.4%

Capital Expenditures vs competitors

How DOCS compares with its peers on the latest reported figures

  • DOCS's LTM Sep 2026 capital expenditures of $4.69M is the smallest of the 10 companies compared; the peer median is $274.89M.
  • Its year-over-year change of -38.4% is the lowest of 10, against a peer median of +3.8%.
  • Capital expenditures amounts to 0.7% of revenue for DOCS, versus a peer median of 3.3%.
DOCS Competitors Peer median
Capital Expenditures for DOCS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EHCEncompass Health CorporationLTM Jun 2026$799.1M +19.9%+8.0%12.9%
VTRSViatris Inc.LTM Jun 2026$457.7M +23.9%-8.2%3.1%
COOThe Cooper Companies, Inc.LTM Jul 2026$355.3M -12.1%+14.4%8.4%
SOLVSolventum CorporationLTM Jun 2026$327M -25.5%+14.7%3.9%
ICLRICON Public Limited CompanyLTM Jun 2026$274.89M +63.5%+7.0%3.3%
RVTYRevvity, Inc.LTM Jul 2026$69.52M -14.8%-5.0%2.4%
GHGuardant Health, Inc.LTM Sep 2026$58.67M +49.2%-14.6%4.6%
TEMTempus AI, Inc.LTM Sep 2026$30M +3.8%+14.1%2.0%
HQYHealthEquity, Inc.LTM Jul 2026$18.51M -32.2%-74.5%1.4%
DOCSDoximity, Inc.LTM Sep 2026$4.69M -38.4%+13.2%0.7%
Peer median (excluding DOCS) $274.89M+3.8%+7.0%3.3%

Competitors are the stored peer set for DOCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income154.78M112.82M147.58M223.19M196.05M
Depreciation & Amortization5.04M10.28M10.27M10.66M14.38M
Deferred Income Tax(41.25M)13.23M(8.59M)(11.59M)32.14M
Stock-Based Compensation31.44M47.83M51.08M72.39M121.63M
Change in Working Capital(40.33M)(21.03M)(24.52M)(24.1M)(45.7M)
Accounts Receivables(31.02M)(26.24M)3.99M(27.21M)(16.88M)
Inventory00000
Accounts Payables8.66M(195K)8.33M(663K)4.27M
Other Working Capital(17.98M)5.4M(36.85M)3.77M(33.09M)
Other Non-Cash Items16.89M16.47M8.29M2.72M7.96M
Operating Cash Flow126.58M179.6M184.1M273.27M326.46M
Capital Expenditures(5.7M)(6.18M)(5.8M)(6.53M)(8.96M)
Acquisitions (Net)0(53.5M)00(26.53M)
Purchases of Investments(1.32B)(190.56M)(472.87M)(675.56M)(389.16M)
Sales of Investments681.72M190.32M509.85M652.78M571.82M
Other Investing Activities595K0(5.65M)00
Investing Cash Flow(640.57M)(59.92M)31.19M(29.3M)147.17M
Debt Repayment00000
Common Stock Issued553.91M0023.3M13.68M
Common Stock Repurchased(2.7M)(85.32M)(280.72M)(120.29M)(431.65M)
Dividends Paid00000
Other Financing Activities9.21M10.86M4.19M(34.15M)(46.09M)
Financing Cash Flow560.42M(74.46M)(276.52M)(131.14M)(464.06M)
Effect of Forex Changes00000
Net Change in Cash46.42M45.22M(61.24M)112.83M9.56M
Free Cash Flow120.88M173.42M178.3M266.74M317.5M

Doximity, Inc.

NYSE:DOCS

Intrinsic Alpha fair value

Locked

Current Price

$30.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.